Paul T. Quinlan - SEC Form 4 Insider Trading Activity
General Counsel
Summary
Updated Aug 16, 2026
Paul T. Quinlan has filed 2 SEC Form 4 filings across 1 company in the last 90 days - selling. Lifetime open-market sales: $5.72M.
Profile
Paul T. Quinlan is General Counsel at Oruka Therapeutics, Inc. (ORKA). Quinlan has reported 3 insider filings with the SEC since 2026. The most recent filing was in June 2026.
- Role
- General Counsel
Board memberships
- Oruka Therapeutics, Inc.
Trading Pattern
InsiderAlpha's records for Paul T. Quinlan go back to 2026: 4 primary Form 4 filings, an average of 4.0 per year. 10 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Career & Filing History
Every role Paul T. Quinlan has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- General Counsel at Oruka Therapeutics, Inc. (ORKA) - 4 filings, 2026
Recent Transactions
11Companies - Last 90 Days
1- Oruka Therapeutics, Inc. (ORKA) - 2 filings, last 2026-08-14
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Paul T. Quinlan has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $300.01M of ORKA open-market activity in the last 12 months
- Carl Dambkowski - $8.65M of ORKA open-market activity in the last 12 months
- Arjun Agarwal - $3.35M of ORKA open-market activity in the last 12 months
- Joana Goncalves - $3.03M of ORKA open-market activity in the last 12 months
- Laura Lee Sandler - $1.40M of ORKA open-market activity in the last 12 months
- Lawrence Otto Klein - $192K of ORKA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Paul T. Quinlan?
Paul T. Quinlan is General Counsel at Oruka Therapeutics, Inc. (ORKA). Quinlan has reported 3 insider filings with the SEC since 2026. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Paul T. Quinlan submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Paul T. Quinlan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($5.72M) across all tracked filings.
Where can I see all of Paul T. Quinlan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Get alerts when Paul T. Quinlan files a new Form 4
Track every insider buy in real time, with AI-scored daily trade ideas and 10b5-1 plan flags.
Free during early access · No credit card required